Ftse Mib
33.739,90
-0,08%
DAX
19.848,77
-0,34%
S&P 500
6.040,04
1,10%
NASDAQ
20.031,13
1,35%
Bitcoin
98.165,42
-0,53%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Revolution Medicines Inc (RVMD) Revolution Medicines Inc (RVMD) Notizie

Revolution Medicines Inc

RVMD
44,39
0,46 (1,05%)
24 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
05/12/202422:05GLOBERevolution Medicines Announces Closing of Upsized Public..
04/12/202404:38GLOBERevolution Medicines Announces Pricing of Upsized $750.0..
02/12/202422:31GLOBERevolution Medicines Announces Commencement of Public..
02/12/202413:30GLOBERevolution Medicines Provides Clinical Updates from its..
27/11/202422:05GLOBERevolution Medicines to Host RAS(ON) Inhibitor Clinical..
06/11/202422:02GLOBERevolution Medicines Reports Third Quarter 2024 Financial..
05/11/202415:00GLOBERevolution Medicines to Participate in Upcoming Investor..
30/10/202421:05GLOBERevolution Medicines to Report Financial Results for Third..
25/10/202410:15GLOBERevolution Medicines Presents Initial Data from RMC-9805..
23/10/202412:00GLOBERevolution Medicines Presents Updated Data from RMC-6236..
21/10/202422:05GLOBERevolution Medicines Announces First Patient Dosed in Phase..
07/10/202415:00GLOBERevolution Medicines to Deliver Multiple Presentations at..
23/8/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202422:14EDGAR2Form 144 - Report of proposed sale of securities
07/8/202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202423:34EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/8/202423:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/8/202422:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202422:05GLOBERevolution Medicines Reports Second Quarter 2024 Financial..
07/8/202422:05EDGAR2Form 8-K - Current report
31/7/202422:05GLOBERevolution Medicines to Report Financial Results for Second..
15/7/202414:03EDGAR2Form 8-K - Current report
11/7/202418:00GLOBERevolution Medicines Announces Publication Demonstrating..
10/7/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/7/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/7/202422:19EDGAR2Form 144 - Report of proposed sale of securities
09/7/202422:19EDGAR2Form 144 - Report of proposed sale of securities
08/7/202422:05GLOBERevolution Medicines to Provide Update on RMC-6236..
05/6/202422:05GLOBERevolution Medicines to Participate in Goldman Sachs 45th..
08/5/202422:02GLOBERevolution Medicines Reports First Quarter 2024 Financial..
01/5/202422:05GLOBERevolution Medicines to Report Financial Results for First..
09/4/202421:34GLOBERevolution Medicines Announces Publication on the Discovery..
08/4/202417:36GLOBERevolution Medicines Announces Publications on the Discovery..
04/4/202422:05GLOBERevolution Medicines to Participate in Upcoming Investor..
28/3/202421:05GLOBERevolution Medicines to Deliver Multiple Presentations at..
05/3/202422:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202423:23EDGAR2Form S-3ASR - Automatic shelf registration statement of..
26/2/202423:04EDGAR2Form S-8 - Securities to be offered to employees in employee..
26/2/202422:05GLOBERevolution Medicines Reports Fourth Quarter and Full Year..
26/2/202422:04EDGAR2Form 8-K - Current report
20/2/202422:05GLOBERevolution Medicines to Report Financial Results for Fourth..
09/2/202423:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202422:05GLOBERevolution Medicines to Participate in Upcoming Investor..
24/1/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202422:18EDGAR2Form 144 - Report of proposed sale of securities
09/1/202420:15EDGAR2Form 8-K - Current report
04/1/202413:00GLOBERevolution Medicines to Present at 42nd Annual J.P...
Apertura: 44,00 Min: 43,49 Max: 44,42
Chiusura: 43,93

La tua Cronologia

NASDAQ
RVMD
Revolution Medicines
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network